Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
Holders of 5% or more of ARTL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Artelo Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Artelo Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Artelo Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 20255:48 PM ET | Farb Daniel Stuart | 13D/A | 0.80%16.4K shares | −6.90 ppfrom 7.70%Below 5% | Oct 20, 2025 | SEC |
| Oct 17, 20255:01 PM ET | Farb Daniel Stuart | 13D/A | 7.70%153.0K shares | 0.00 ppfrom 7.70% | Oct 15, 2025 | SEC |
| Oct 3, 20255:21 PM ET | Farb Daniel Stuart | 13D/A | 7.70%153.0K shares | −2.10 ppfrom 9.80% | Oct 1, 2025 | SEC |
| Sep 19, 202511:58 AM ET | Farb Daniel Stuart | 13D | 9.80%153.0K shares | New | Sep 12, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Artelo Biosciences, Inc. shares.
No Form 144 notices for Artelo Biosciences, Inc. are on file.